AVPR2 and neoplasm: Knocking-out SIRT3 (Fig. 4D) makes Nf1−/− cells insensitive to the antineoplastic effect of NDI1 (Fig. 4F, G), in line with an inhibitory effect on tumor growth of NDI1 that requires SIRT3 activity.